1-7 of 7
Rainer Fietkau
Close
Sort by
Journal Articles

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

Clinical Trials & Observations
Dieter Hoelzer, Jan Walewski, Hartmut Döhner, Andreas Viardot, Wolfgang Hiddemann, Karsten Spiekermann, Hubert Serve, Ulrich Dührsen, Andreas Hüttmann, Eckhard Thiel, Jolanta Dengler, Michael Kneba, Markus Schaich, Ingo G. H. Schmidt-Wolf, Joachim Beck, Bernd Hertenstein, Albrecht Reichle, Katarzyna Domanska-Czyz, Rainer Fietkau, Heinz-August Horst, Harald Rieder, Stefan Schwartz, Thomas Burmeister, Nicola Gökbuget
Journal: Blood
Blood (2014) 124 (26): 3870–3879.
https://doi.org/10.1182/blood-2014-03-563627
Published: 2014
Includes: Supplemental data
Journal Articles

Substantially Improved Outcome of Adult Burkitt Non-Hodgkin Lymphoma and Leukemia Patients with Rituximab and a Short-Intensive Chemotherapy; Report of a Large Prospective Multicenter Trial

Dieter Hoelzer, MD, Jan Walewski, Hartmut Döhner, MD, Mathias Schmid, MD, Wolfgang Hiddemann, MD, PhD, Anja Baumann, MD, Hubert Serve, Prof. Dr. med., Ulrich Dührsen, Andreas Hüttmann, Eckhard Thiel, Jolanta Dengler, MD, Michael Kneba, MD, Markus Schuler, MD, Ingo Schmidt-Wolf, MD, Joachim Beck, MD, Bernd Hertenstein, Albrecht Reichle, Katarzyna Domanska-Czyz, Rainer Fietkau, MD, Heinz-August Horst, MD, Harald Rieder, MD, Stefan Schwartz, MD, Thomas Burmeister, MD, Nicola Goekbuget, MD
Journal: Blood
Blood (2012) 120 (21): 667.
https://doi.org/10.1182/blood.V120.21.667.667
Published: 2012
Journal Articles

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies

Clinical Trials & Observations
Nicola Gökbuget, Michael Kneba, Thorsten Raff, Heiko Trautmann, Claus-Rainer Bartram, Renate Arnold, Rainer Fietkau, Mathias Freund, Arnold Ganser, Wolf-Dieter Ludwig, Georg Maschmeyer, Harald Rieder, Stefan Schwartz, Hubert Serve, Eckhard Thiel, Monika Brüggemann, Dieter Hoelzer
Journal: Blood
Blood (2012) 120 (9): 1868–1876.
https://doi.org/10.1182/blood-2011-09-377713
Published: 2012
Includes: Supplemental data
Journal Articles

Overall Outcome of Relapsed Acute Lymphoblastic Leukemia Can Be Improved by Stem Cell Transplantation and Early Treatment in Stage of Molecular Relapse

Nicola Goekbuget, MD, Daniel Stanze, MD, Renate Arnold, Monika Brueggemann, MD, Rainer Fietkau, MD, Mathias Freund, MD, Arnold Ganser, MD, Wolf-Dieter Ludwig, Georg Maschmeyer, MD, Thorsten Raff, MD, Harald Rieder, MD, Eckhard Thiel, Hubert Serve, MD, Michael Kneba, MD, Dieter Hoelzer, MD
Journal: Blood
Blood (2011) 118 (21): 250.
https://doi.org/10.1182/blood.V118.21.250.250
Published: 2011
Journal Articles

New Definition of Treatment Response in Adult Acute Lymphoblastic Leukemia (ALL): Use of Molecular Markers for Minimal Residual Disease (MRD).

Nicola Goekbuget, MD, Monika Brueggemann, MD, Renate Arnold, MD, Claus-Rainer Bartram, PhD, Rainer Fietkau, MD, Mathias Freund, MD, Arnold Ganser, MD, Michael Kneba, MD, PhD, Thomas Lipp, MD, Wolf-Dieter Ludwig, MD, Georg Maschmeyer, MD, Dorle Messerer, Thorsten Raff, MD, Harald Rieder, MD, Eckhard Thiel, Dieter Hoelzer, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 90.
https://doi.org/10.1182/blood.V114.22.90.90
Published: 2009
Journal Articles

High Survival Rate in Adult Burkitt’s Lymphoma/Leukemia and Diffuse Large B-Cell Lymphoma with Mediastinal Involvement.

Dieter Hoelzer, MD, PhD, Wolfgang Hiddemann, MD, PhD, Anita Baumann, MD, Hartmut Döhner, MD, PhD, Ulrich Dührsen, MD, PhD, Rainer Fietkau, MD, PhD, Martin-Leo Hansmann, MD, PhD, Andreas Hüttmann, MD, PhD, Sebastian Irmer, MD, Stephan Kaun, MD, Michael Kneba, MD, PhD, Albrecht Reichle, MD, PhD, Mathias Schmid, MD, PhD, Ingo Schmidt-Wolf, MD, PhD, Eckard Thiel, MD, PhD, Jan Walewski, MD, Nicola Gökbuget, MD
Journal: Blood
Blood (2007) 110 (11): 518.
https://doi.org/10.1182/blood.V110.11.518.518
Published: 2007
Journal Articles

Improved Outcome in High Risk and Very High Risk ALL by Risk Adapted SCT and in Standard Risk ALL by Intensive Chemotherapy in 713 Adult ALL Patients Treated According to the Prospective GMALL Study 07/2003.

Nicola Gökbuget, MD, Renate Arnold, MD, PhD, Angelika Böhme, MD, PhD, Rainer Fietkau, MD, PhD, Mathias Freund, MD, PhD, Arnold Ganser, MD, PhD, Michael Kneba, MD, PhD, Thomas Lipp, MD, Wolf-Dieter Ludwig, MD, PhD, Georg Maschmeyer, MD, PhD, Dorle Messerer, Harald Rieder, MD, PhD, Eckard Thiel, MD, PhD, Dieter Hoelzer, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 12.
https://doi.org/10.1182/blood.V110.11.12.12
Published: 2007